The Trajectory and Influencing Factors of Cognitive Level in ICU Delirium Patients After Transfer Out of the ICU
Launched by ZUNYI MEDICAL COLLEGE · Nov 3, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
A prospective longitudinal cohort study will be conducted in the ICU of a tertiary grade-A hospital in Guizhou Province. The study aims to recruit 240 patients diagnosed with ICU delirium, who were carefully selected based on predefined inclusion and exclusion criteria (Inclusion and exclusion criteria were as follows). The study is anticipated to commence in September 2024 and conclude in May 2026.
The inclusion criteria are:
1. Patients diagnosed with delirium by Confusion Assessment Model for Intensive Care Unit.
2. Age ≥ 18 years old.
3. Length of stay in ICU ≥24h.
4. Patients were ab...
Gender
ALL
Eligibility criteria
- The inclusion criteria are:
- • 1. Patients diagnosed with delirium by CAM-ICU.
- • 2. Age ≥ 18 years old.
- • 3. Length of stay in ICU ≥24h.
- • 4. Patients were able to complete the questionnaire by themselves or with the cooperation of their family members.
- • 5. Patients or family members gave informed consent and participated in the survey voluntarily.
- The exclusion criteria are:
- • 1. Previously diagnosed with dementia.
- • 2. Mental illness or history of mental illness.
- • 3. Suffering from traumatic brain injury, cerebrovascular disease, stroke, cranial surgery, intracranial infections, and other conditions that may affect cognitive function.
- • 4. Presence of visual, hearing or communication impairments.
About Zunyi Medical College
Zunyi Medical College, a prominent institution in medical education and research located in Guizhou Province, China, is dedicated to advancing healthcare through innovative clinical trials. With a focus on fostering academic excellence and translating research findings into clinical practice, the college collaborates with various healthcare professionals and institutions to conduct rigorous studies that address pressing medical challenges. Its commitment to ethical standards and patient safety ensures that all trials contribute valuable insights to the medical community while enhancing the quality of care for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guiyang, Guizhou, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported